World Journal of Diabetes - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Zhu YX, Zhang W, Qu HL, Zhang Y, Zhou RQ, Li P, Wang F, Zhang Y, Liu HH, Li S, Dong Q, Dou KF, Guo YL, Li JJ, Xu RX. Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway. World J Diabetes 2025; 16(12): 112423 [PMID: 41480600 DOI: 10.4239/wjd.v16.i12.112423]
URL:	https://www.wjgnet.com/1948-9358/full/v16/i12/112423.htm

(28) (41) (0) (0) (0) (1) (834) (1)

Number	Citing Articles
1	Ke Su, Pei-Yan Cao, Gan Chen, Ke Wu. Letter to the Editor: Is the cellular attribution of liraglutide action in diabetic cardiomyopathy conclusive?. World Journal of Diabetes 2026; 17(7): 117243 doi: 10.4239/wjd.117243 Abstract(6) \| Core Tip(7) \| Full Article(HTML)(15) \| Full Article (PDF)-379K(3) \| Full Article with Cover (PDF)-782K(2) \| Full Article (XML)-41K(1) \| Audio-291K(1) \| Peer-Review Report-323K(3) \| Answering Reviewers-173K(2) \| Times Cited (0) \| Total Visits (21) \| Open

Number

Citing Articles

Ke Su, Pei-Yan Cao, Gan Chen, Ke Wu. Letter to the Editor: Is the cellular attribution of liraglutide action in diabetic cardiomyopathy conclusive?. World Journal of Diabetes 2026; 17(7): 117243 doi: 10.4239/wjd.117243

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.